Viewing Study NCT03013218


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2026-03-06 @ 4:56 PM
Study NCT ID: NCT03013218
Status: COMPLETED
Last Update Posted: 2025-08-01
First Post: 2016-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
Sponsor: ALX Oncology Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module